Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93 USD | +2.50% | +7.08% | +0.82% |
Apr. 25 | Transcript : Blueprint Medicines Corporation - Special Call | |
Mar. 22 | Blueprint Medicines Insider Sold Shares Worth $2,188,265, According to a Recent SEC Filing | MT |
Business Summary
Number of employees: 655
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Precision Therapies
100.0
%
| 204 | 100.0 % | 249 | 100.0 % | +22.22% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
91.1
%
| 190 | 93.3 % | 227 | 91.1 % | +19.38% |
Rest of World
8.9
%
| 14 | 6.7 % | 22 | 8.9 % | +61.52% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 16-01-04 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Director of Finance/CFO | 52 | 14-08-31 | |
Jeffrey Albers
CHM | Chairman | 52 | 14-07-23 |
Janet Loesberg
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-02-29 |
Becker Hewes
CTO | Chief Tech/Sci/R&D Officer | 58 | 20-04-30 |
Percy Carter
CTO | Chief Tech/Sci/R&D Officer | 53 | 21-05-18 |
Christina Rossi
COO | Chief Operating Officer | 48 | 18-10-28 |
Chief Tech/Sci/R&D Officer | 61 | 17-10-09 | |
Tracey McCain
CMP | Compliance Officer | 56 | 16-09-05 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Lynn Seely
BRD | Director/Board Member | 65 | 16-04-13 |
Alexis Borisy
FOU | Founder | 52 | 08-09-30 |
Lonnel Coats
BRD | Director/Board Member | 58 | 16-02-03 |
Founder | 67 | 08-09-30 | |
Mark Goldberg
BRD | Director/Board Member | 69 | 15-06-24 |
Daniella Beckman
BRD | Director/Board Member | 45 | 21-12-07 |
Jeffrey Albers
CHM | Chairman | 52 | 14-07-23 |
Kathryn Haviland
CEO | Chief Executive Officer | 48 | 16-01-04 |
Habib Dable
BRD | Director/Board Member | 54 | 22-06-22 |
John Tsai
BRD | Director/Board Member | 57 | 23-01-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 62,814,862 | 62,297,087 ( 99.18 %) | 0 | 99.18 % |
Company contact information
Blueprint Medicines Corp.
45 Sidney Street
02139, Cambridge
+617 374 7580
http://www.blueprintmedicines.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.82% | 5.84B | |
+1.51% | 42.75B | |
+47.81% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- BPMC Stock
- Company Blueprint Medicines Corporation